LEGEND BIOTECH CORPORATION

(LEGN)
  Report
Delayed Nasdaq  -  05/20 04:00:00 pm EDT
42.61 USD   +2.63%
05/18Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma With Updated Data From BCMA CAR-T Studies at 2022 ASCO and EHA
BU
05/10Genscript Biotech's Nasdaq-listed Unit Promotes Finance VP to CFO; Shares Slip 5%
MT
05/09Legend Biotech Names New CFO
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about LEGEND BIOTECH CORPORATION
05/18Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma Wit..
BU
05/09Legend Biotech Names New CFO
MT
05/09Legend Biotech Appoints Lori Macomber as Chief Financial Officer
BU
05/09Legend Biotech Appoints Lori Macomber as Chief Financial Officer
CI
05/06Legend Biotech Announces Participation in Upcoming Investor Conferences
BU
04/21Legend Biotech Gets $50 Million Milestone Payment Under Deal With Janssen Biotech for C..
MT
04/21LEGEND BIOTECH : Achieves Milestone Under Collaboration Agreement with Janssen Biotech, In..
PU
04/21Legend Biotech Achieves $50 Million Milestone Payment Under Janssen Deal
DJ
04/03Legend Biotech Announces Executive Changes
CI
04/01LEGEND BIOTECH : Announces Appointment of Global Head of Research and Early Development - ..
PU
04/01Legend Biotech Announces Appointment of Global Head of Research and Early Development
BU
04/01Legend Biotech Corporation Announces Appointment of Guowei Fang as Global Head of Resea..
CI
03/25Legend Biotech Gets Positive CHMP Opinion for Carvykti for Relapsed, Refractory Multipl..
MT
03/25J&J's Janssen, Legend Get CHMP Backing for Carvykti Blood Cancer Drug
DJ
03/25LEGEND BIOTECH : CARVYKTI« (ciltacabtagene autoleucel) Receives Positive CHMP Opinion for ..
PU
More most relevant news
All news about LEGEND BIOTECH CORPORATION
05/18Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma Wit..
BU
05/10Genscript Biotech's Nasdaq-listed Unit Promotes Finance VP to CFO; Shares Slip 5%
MT
05/09Legend Biotech Names New CFO
MT
05/09Legend Biotech Appoints Lori Macomber as Chief Financial Officer
BU
05/09Legend Biotech Appoints Lori Macomber as Chief Financial Officer
CI
05/06Legend Biotech Announces Participation in Upcoming Investor Conferences
BU
04/22Genscript Biotech Unit Receives $50 Million Milestone Payment from Janssen Biotech
MT
04/21Legend Biotech Gets $50 Million Milestone Payment Under Deal With Janssen Biotech for C..
MT
04/21LEGEND BIOTECH : Achieves Milestone Under Collaboration Agreement with Janssen Biotech, In..
PU
04/21Legend Biotech Achieves $50 Million Milestone Payment Under Janssen Deal
DJ
More news
News in other languages on LEGEND BIOTECH CORPORATION
05/10L'unité de Genscript Biotech cotée au Nasdaq promeut le vice-président des finances au ..
04/22L'unité de Genscript Biotech reçoit un paiement d'étape de 50 millions de dollars de Ja..
04/21Legend Biotech reçoit un paiement d'étape de 50 millions de dollars dans le cadre de l'..
04/03Legend Biotech annonce des changements de direction
04/01Legend Biotech Corporation annonce la nomination de Guowei Fang au poste de responsable..
03/25MÄRKTE USA/Uneinheitlich - Zurückhaltung vor dem Wochenende
03/25LATE BRIEFING - Unternehmen und Märkte -2-
03/25MÄRKTE USA/Leichte Abgaben - Anfangsgewinne nicht verteidigt
03/25MÄRKTE USA/Börsen zum Start zurückhaltend
03/25Legend Biotech obtient un avis positif du CHMP sur Carvykti pour le myélome multiple ré..
More news
Analyst Recommendations on LEGEND BIOTECH CORPORATION
03/15Barclays Starts Legend Biotech at Overweight With $53 Price Target
MT
03/07Morgan Stanley Adjusts Legend Biotech Price Target to $55 From $51, Maintains Overweigh..
MT
03/01BTIG Research Adjusts Legend Biotech Price Target to $75 From $65, Maintains Buy Rating
MT
01/31Morgan Stanley Upgrades Legend Biotech to Overweight From Equalweight; Price Target is ..
MT
01/06Morgan Stanley Downgrades Legend Biotech to Equalweight from Overweight, Keeps $51 Pric..
MT
More recommendations
Press releases
05/18Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma Wit..
BU
05/09Legend Biotech Appoints Lori Macomber as Chief Financial Officer
BU
05/06Legend Biotech Announces Participation in Upcoming Investor Conferences
BU
04/21LEGEND BIOTECH : Achieves Milestone Under Collaboration Agreement with Janssen Biotech, In..
PU
04/01LEGEND BIOTECH : Announces Appointment of Global Head of Research and Early Development - ..
PU
More press releases
Upcoming event on LEGEND BIOTECH CORPORATION